October Pharma S.A.E (EGX:OCPH)

October Pharma S.A.E Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 26, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,234	1,200	1,200	978	600	396
Market Cap Growth	22.71%	-	22.68%	63.02%	51.52%	3.61%
Enterprise Value	1,741	1,518	1,257	1,193	853	635
Last Close Price	102.82	97.50	97.50	77.49	46.11	29.97
PE Ratio	9.11	7.98	10.55	8.16	6.80	11.71
PS Ratio	1.03	1.19	1.65	1.49	1.10	0.76
PB Ratio	1.90	2.04	2.82	2.88	2.36	2.19
P/TBV Ratio	2.61	2.41	3.67	4.18	4.25	6.59
P/FCF Ratio	10.21	-	4.04	12.59	6.30
P/OCF Ratio	61.93	7.85	-	3.73	11.26	4.12
EV/Sales Ratio	1.46	1.50	1.73	1.82	1.57	1.21
EV/EBITDA Ratio	5.10	4.61	5.68	5.52	5.20	5.52
EV/EBIT Ratio	5.45	4.94	6.31	6.10	5.88	6.45
EV/FCF Ratio	-67.09	12.91	-	4.92	17.90	10.11
Debt / Equity Ratio	0.86	0.55	0.76	0.22	0.98	1.43
Debt / EBITDA Ratio	1.62	0.98	1.46	0.34	1.52	2.24
Debt / FCF Ratio	-	2.76	-	0.31	5.21	4.10
Asset Turnover	0.93	0.97	0.97	1.13	0.95	0.97
Inventory Turnover	2.84	2.45	1.78	2.15	2.55	3.36
Quick Ratio	0.36	0.56	0.36	0.75	0.31	0.33
Current Ratio	1.58	1.82	1.54	2.17	1.38	1.12
Return on Equity (ROE)	28.01%	35.89%	34.18%	40.38%	40.64%	20.14%
Return on Assets (ROA)	15.57%	18.38%	16.57%	21.09%	15.84%	11.34%
Return on Capital (ROIC)	19.14%	23.10%	21.43%	26.69%	19.29%	13.62%
Return on Capital Employed (ROCE)	42.50%	45.10%	37.90%	48.80%	44.50%	37.30%
Earnings Yield	10.97%	15.18%	10.90%	12.25%	14.71%	8.54%
FCF Yield	-2.10%	9.80%	-15.42%	24.79%	7.94%	15.87%
Dividend Yield	2.43%	2.56%	-	-	3.25%	-
Payout Ratio	33.58%	9.86%	34.16%	28.54%	16.83%	29.34%
Total Shareholder Return	2.43%	2.56%	-	-	3.25%	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.